These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5860126)

  • 1. A previously inoperable case of avarian carcinoma rendered operable by means of treatment with a cytostatic agent.
    Pystynen P; Pankamaa P
    Ann Chir Gynaecol Fenn; 1965; 54(3):328-30. PubMed ID: 5860126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the effects of Cyclophosphamide, Cytembena and Ypenyl in the treatment of inoperable ovarian neoplasms].
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík J
    Cesk Gynekol; 1971 Sep; 36(7):431-3. PubMed ID: 5110665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experiences with the treatment of ovarian neoplasms with cytostatics].
    Kliment V; Stefanovic J; Kovalcíková J; Deák E; Ziak F; Manicová G; Rappová E
    Cesk Gynekol; 1971 Sep; 36(7):429-30. PubMed ID: 5110664
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation of histological findings and immediate therapeutical effect of cytostatic treatment in ovarian carcinoma].
    Popović ND; Nikolin L
    Med Pregl; 1976; 29(9-10):411-3. PubMed ID: 1004385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
    Brandl K
    Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late recurrence of ovarian carcinoma treated with endoxan].
    Przystasz T
    Wiad Lek; 1976 Aug; 29(15):1365-7. PubMed ID: 969520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with the cytostatic treatment of malignant ovarian tumors].
    Ferkó S; Gál I; Szönyi I
    Acta Chir Acad Sci Hung; 1967; 8(1):75-87. PubMed ID: 5598288
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of ovarian carcinoma with cytostatics].
    Popović D
    Med Pregl; 1970; 23(5):207-9. PubMed ID: 5206723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our observations on the treatment of ovarian carcinoma with cytostatics].
    Krstalić V; Krstalić N
    Med Pregl; 1978; 31(11-12):521-2. PubMed ID: 739967
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 11. Ovarian carcinoma treated with cyclophosphamide (Endoxan).
    Hsii FP; Jayaratnam FJ; Siang SC
    Singapore Med J; 1968 Sep; 9(3):195-7. PubMed ID: 5710986
    [No Abstract]   [Full Text] [Related]  

  • 12. [A patient with severe deglutition complaints following cytostatic treatment].
    Boelen HJ; Verhoeven AT
    Ned Tijdschr Geneeskd; 1978 Aug; 122(34):1262-3. PubMed ID: 692750
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of ovarian carcinoma in the Univ.-Frauenklinik Tübingen since 1957 and its results].
    Pfleiderer A; Kiyan S
    Med Welt; 1967 Dec; 51():3095-102. PubMed ID: 5608859
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cytostatic therapy on the metabolism of purine in female genital carcinoma].
    Popović I; Popović D; Stefanović O
    Med Pregl; 1969; 22(5):295-300. PubMed ID: 5201467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant chemotherapy in ovarian carcinoma].
    Conte PF; Bruzzone M; Carnino F
    Minerva Ginecol; 1984 Apr; 36(4):191-4. PubMed ID: 6540425
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent.
    Vincent F; Michel M; Marrast AC; Bensousan TA; Glotz D; Duboust A
    Transplant Proc; 1995 Aug; 27(4):2432. PubMed ID: 7652865
    [No Abstract]   [Full Text] [Related]  

  • 18. [Palliative and second-look operations in ovarian cancer].
    Grünberger V; Dobrovits H; Hoffelner L
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():131-4. PubMed ID: 6163684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of early second-look laparotomy in the treatment of ovarian cancer. Preliminary results].
    Giana M; Cottafavi M
    Minerva Med; 1983 Jun; 74(24):1399-402. PubMed ID: 6682943
    [No Abstract]   [Full Text] [Related]  

  • 20. Polychemotherapy in ovarian cancer: treatment with Adriamycin, BCNU and cyclophosphamide vs. Adriamycin and cyclophosphamide.
    Mazzei T; Bonazza M; Amunni G; Scarselli G; Branconi F; Massi GB
    Chemioterapia; 1984 Feb; 3(1):10-5. PubMed ID: 6535650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.